GDF-15, a future therapeutic target of glucolipid metabolic disorders and cardiovascular diseaseQing-Ao Xiao, Xuan Xia, Qian He et al.|Biomedicine & Pharmacotherapy|2021Cited by 50
Amlexanox reversed non-alcoholic fatty liver disease through IKKε inhibition of hepatic stellate cellQian He, Xiulan Zou, Wei Wang et al.|Life Sciences|2019Cited by 28
Long-term subcutaneous injection of lipopolysaccharides and high-fat diet induced non-alcoholic fatty liver disease through IKKε/ NF-κB signalingQian He, Xiulan Zou, Jun Zeng et al.|Biochemical and Biophysical Research Communications|2020Cited by 20
Role of IKKε in the Metabolic Diseases: Physiology, Pathophysiology, and PharmacologyQing-Ao Xiao, Xuan Xia, Jun Zeng et al.|Frontiers in Pharmacology|2022Cited by 5